Follow-The-Filings

Security

Autolus Therapeutics PLC · SPON ADS

Equity holders as of 2026 Q1 (each manager’s latest book)

6 owners 2 new 1 exit max 0.0% (Renaissance Technologies LLC)

owners 6
max % 0.0%
tracked value $6M
qoq N 2 A 1 R 3 E 1

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Renaissance Technologies LLC 2026 Q1 0.0% Reduce 0.00 pp 2,299,499 $3M hist
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% New 0.0% 971,691 $1M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 459,404 $634 hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Add 0.00 pp 426,983 $589 hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% New 0.0% 204,728 $283 hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Reduce 0.00 pp 26,682 $37 hist
Two Sigma Investments, LP exited 2025 Q4 last 2025 Q3 0.0% Exit 0.00 pp 172,143 $281 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $75.39M
Gross profit * -$20.98M
Gross margin * -27.8%
Net income -$39.81M -$220.66M -$287.53M
Net margin * -381.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $393.88M $660.93M $435.92M
Total non-current assets * $66.09M $121.8M $153.15M
Total assets $459.97M $782.72M $589.07M
Total current liabilities $39.64M $60.74M $73.44M
Total non-current liabilities * $153.41M $294.66M $337.5M
Total equity $266.92M $427.32M $178.13M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$145.59M -$206.27M -$283.57M
Cash from investing -$10.99M -$394.55M $158.46M
Cash from financing -$883,000 $589.55M -$4.34M
Net change in cash -$142.43M -$11.53M -$123.17M

ownership over time

filing count by report period · click a bar for that quarter’s holders